Blog | Life Sciences
30th April,   2025
Gouthami Sagar is an experienced Product Owner with 9+ years in IT, specializing in life sciences and healthcare. She has strong expertise in patient engagement, adherence, product management, and stakeholder engagement. As a domain matter expert, Gouthami focuses on improving patient outcomes by enhancing engagement and adherence strategies for a leading life sciences client.
Nihar is a Senior Manager, Life Sciences Strategy and Consulting with over 16 years of experience in leading digital transformation and product innovation initiatives. He has partnered with global Life Sciences organizations to formulate digital roadmaps, scale AI capabilities, and implement cutting-edge solutions across R&D, Commercial Ops, and Patient Engagement. With deep domain expertise and passion for innovation, Nihar is currently focused on enabling leading BioPharmas to accelerate their digital journeys and deliver measurable business impact.
The industrial automation in life sciences market was estimated at around USD 5.7 billion in 2023 and is anticipated to nearly double, reaching about USD 12.8 billion by 2032, reflecting a robust compound annual growth rate (CAGR) of 9.2%. This rapid expansion highlights the growing importance of automation in life sciences to improve verification and validation testing, operational efficiency, and compliance.
V&V processes are crucial to regulatory requirements and organizational practices. Traditionally, these processes have largely been document-driven, often leaving less time for the critical task of testing. As the industry pivots toward more fast-paced, automated digital models, adopting efficient solutions like CSA will reduce duplication, ensuring production efficiency and reliable results. While verification ensures the design requirements are fulfilled, validation proves that the product works as intended in the real world. To mitigate risks, V&V ensures regulatory compliance, robust product quality, and patient safety. Organizations can also leverage digital health solutions for life sciences from Brillio, a leading tech solution provider, to complement V&V processes with cutting-edge digital technologies. The problem, however, lies in its traditional approach that deals with computerized system certifications. These are often bogged down by excessive documentation that eats up resources and hinders the testing phase’s overall effectiveness.
Some of the key challenges faced by enterprises during the various phases of verification and validation are as follows:
Computerized Systems Assurance (CSA) streamlines validation by concentrating efforts on critical areas. Instead of applying the same validation rules across systems, CSA tailors validation efforts based on a system’s importance and risk profile. For organizations looking to extend AI-driven efficiencies beyond V&V, Brillio also offers AI-driven solutions for customer care in life sciences.
Our life sciences IT solution brings this vision to life, ensuring efficiency, accuracy, and foresight with the following seven automation features:
Our solution automates all stages of the verification and validation journey, from documentation to testing, ensuring that the validation process is streamlined, proactive, and future-proof. In a world of constantly changing regulations and complex systems, intelligent life science automation isn’t just a luxury but a necessity. By embracing automation in life sciences, companies can improve efficiency and compliance and ensure safer and more reliable products. To learn more about how Brillio can support your life sciences organization, contact us today.